SMSheena McCormackMDVideoHIVHIV Prevention Review Meeting 2022New Drugs and Strategies for PrEP and What This Means for PEP? - Sheena McCormack, MDView Video
RERichard ElionMDVideoHIVHIV Prevention Review Meeting 2022Existing Drugs and Strategies for PrEP - Richard Elion, MDView Video
VideoHIVHIV Prevention Review Meeting 2022Existing Drugs and Strategies for PEP - Elizabeth Anne Bukusi & Victor Ocholla OmolloView Video
MSMark SulkowskiMDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2022New Therapeutic Combination Trials – What Are Their Potential to Achieve a Cure? - Mark SulkowskiView Video
MLMassimo LevreroMDVideoViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2022What to Watch Preclinical Therapeutics with Novel Mechanisms of Action - Massimo LevreroView Video
JFJohn FlahertyPharmDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2022Bulevirtide - Data from Real World Usage after Approval in Europe - John FlahertyView Slideset
GWGrace WangMDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2022Development of Assembly Next Generation Core Inhibitors - Grace WangView Slideset
ETEmily ThiPhDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2022Evidence of T Cell Restoration after siRNA Therapy - Emily ThiView Slideset
MBMichael BiermerMDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2022Cam-N Jnj-6379. Lessons Learned From Reef-1 and -2 Studies - Michael BiermerView Slideset
BTBarbara TestoniPhDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2022How HBV RNA and HBcrAg Relate to cccDNA Transcriptional Activity - Barbara TestoniView Slideset
GLGeorg LauerPhD, MDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2022HBV-Specific T Cell Profile Associated with Functional Cure - Georg LauerView Slideset
PLPietro LamperticoMD, PhDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2022Why We Should Be Careful Using NA Withdrawal as a Therapeutic Option - Pietro LamperticoView Slideset
